Name (Synonyms) | Correlation | |
---|---|---|
drug1547 | Laboratory tests Wiki | 1.00 |
drug1833 | Nasal Dexamethasone Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.08 |
D007239 | Infection NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.
Description: Evaluation of the clinical status of patients after randomization, defined as a two point improvement in the WHO 7-point Ordinal Scale
Measure: Time of clinical improvement Time: 10 days after randomizationDescription: All-cause mortality rates at 28 days after randomization
Measure: Time-to-death from all causes Time: 28 days after randomizationDescription: Ventilator-free days, defined as alive and not requiring mechanical ventilation, at 10 days after randomization.
Measure: Time free from mechanical ventilation Time: 10 days after randomizationDescription: Virological measurements, including proportions with detection of viral RNA over time and measurements of viral RNA titer area under the curve (AUC).
Measure: Viral load Time: 10 days after randomizationDescription: Length of hospital stay in days
Measure: Length of hospital stay Time: 10 days after randomization